Trichosporon asahii. Blood-stream infection in a non-cancer patient receiving combination antifungal therapy.
O'Gorman
C
C
Department of Medical Microbiology, Kelvin Laboratories, Royal Victoria Hospital, Belfast, Northern Ireland, BT12 6BA. Ciaran.O'Gorman@bll.n-i.nhs.uk
McMullan
R
R
Webb
C H
CH
Bedi
A
A
D000062:Accidents, Occupational; D000368:Aged; D000383:Agriculture; D000666:Amphotericin B / Q000494:pharmacology / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D000077336:Caspofungin; D004359:Drug Therapy, Combination; D054714:Echinocandins; D017809:Fatal Outcome; D006801:Humans; D055666:Lipopeptides; D008297:Male; D009102:Multiple Organ Failure / Q000382:microbiology; D009181:Mycoses / Q000188:drug therapy* / Q000382:microbiology; D010456:Peptides, Cyclic / Q000494:pharmacology / Q000627:therapeutic use*; D018805:Sepsis / Q000382:microbiology*; D013045:Species Specificity; D014250:Trichosporon / Q000187:drug effects / Q000302:isolation & purification*
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; D000666:Amphotericin B; D000077336:Caspofungin